HIV Cure Symposium

HIV stably integrated within the host cell genome is considered the final hurdle to cure one of the most important infectious diseases mankind has ever faced. Latent HIV reservoir is able to refuel infection once the treatment is stopped and therefore a better understanding of both, the composition and the size of this reservoir will be important to aid the development of cure strategies as well as to monitor the efficacy of therapeutic interventions to reduce the HIV reservoir. The HIV Cure and Reservoir Symposium will comprehensively summarize the state of the art in HIV cure strategies and diagnostic tools to monitor therapeutic interventions. The Symposium will take place in the picturesque city of Ghent, Belgium where an international expert panel will guide you through the newest developments in the HIV cure field, focusing on reservoir characterization and novel clinical strategies to achieve HIV cure.



Target audience

The symposium aims to attract a broad public of basic and translational researchers with an interest in HIV research or in other persistent infectious diseases.



Expected number of participants

150-200



Final program

Monday 16.09.2019

 SpeakerSubject
12.30-13.10Registration
13:10-13:30Linos VandekerckhoveWelcome
TREATMENT INTERRUPTION STUDIES:
in search of a biomarker for Post Treatment Controle (PTC)
13:30-14:00Eric Florence Treatment interruption in patients with a low reservoir: ISALA study
14:00-14:30John FraterBiomarkers in treatment interruption studies
14:30-14:502 selected abstracts2x10 min bullet presentation:
R. Scutari
L. Vandekerckhove
14:50-15:20Coffee Break
UNMASKING THE VIRAL RESERVOIR : Themed discussion
15:20-16:20Maria Buzon, Marion Pardon, Susan Pereira RibeiroUnmasking the viral reservoir for downstream analysis
16:20-16:503 selected abstracts3x10 min bullet presentation
R. Schober
J. Janssens
K. Gärtner
16:50-17:00Round table and discussion
17:00-17:20Coffee Break
HIV TODAY: A RESEARCHER AND A PATIENT PERSPECTIVE
17:20-17:25
Linos VandekerckhoveAnnouncement inaugural lecture
17:25-18:00Guido VanhamA lifetime search for eliminating HIV
18:00-18:15Jonathan BossaerPositively Alive
NETWORK RECEPTION

Tuesday 17.09.2019

 SpeakerSubject
THE LAST HURDLE TOWARDS CURE
09:00-9:30Meritxell GenescàResident memory T cells as source of viral reservoir
09.30-10.00Monique NijhuisResults of the ICISTEM cohort
10.00-10.202 selected abstracts2x10 min bullet presentation
K. Held
R. Verdikt
10:20-10:50Coffee Break
THE ORIGIN OF PLASMA VIRUS
10.50-11.20Lisa FrenkelThe active HIV reservoir during suppressive ART
11.20-11.50Marie-Angélique De ScheerderIdentifying the source of plasma virus during analytical treatment interruption
11.50-12.102 selected abstracts2x10 min bullet presentation
K. Fisher
L. Hebberecht
12:10-13:30Lunch
BLOCK AND LOCK VS SHOCK AND KILL
13:30-14:10Zeger Debyser & Carine Van LintBlock and lock vs Shock and kill
14:10-14:302 selected abstracts2x10 min bullet presentation
U. Lange
P. André
14:30-15:00Round table and discussion
15:00-16:00Coffee Break
+ poster session
IMMUNE CHARACTERISATION AND THERAPEUTIC STRATEGIES
16:00-16:30Philipp AdamsPhenotypically characterization of elite and viremic controllers
16:30-17:00Ole SogaardTherapeutic vaccination/ Ab treatment to achieve a functional cure
17:00-17:202 selected abstracts2x10 min bullet presentation
W. van der Heijden
V. Avettand-Fenoel
17:20-17:30Linos VandekerckhoveClosing Remarks
08.00-09.00Registration


Practical Information

Registration

Click here for more information

Venue

The symposium will take place in

Auditorium Oehoe (E1.002)

Block E

Coupure Links 653

9000 Ghent



Abstract submission

Abstract submission will open from the 20th of March until 30th of July.

Abstract content and editing are the responsibility of submitting author. Organizers will review abstracts and selections will be made based on quality of content. Dissemination of the results will be made on August 15th. 4 abstracts will be selected for a short oral presentation at the symposium and those will be awarded with complimentary registration. All abstracts are assigned a poster number for poster presentation during a poster session during the meeting.

Abstract Format

• 2200 characters count including spaces. Also includes title, authors and affiliations.
• No email addresses, phone numbers, hyperlinks, keyword lists, comments, text or image boxes.
• Paragraph breaks between Title, Author & Institute, and abstract body.
• Arial, 11 point, black font.
• For Greek and Scientific symbols, use the Symbol option under the Insert tab in Microsoft Word (or equivalent option in other applications).
• Single spacing, one-inch margins, left justified.
• One abstract per submitting author per meeting. Submitting author and account name must match. Submitting author must be underlined.

Disclaimer

Submission of the abstract signifies consent to publication of the abstract in the Journal of Virus Eradication.

Abstract submission

To submit your abstract, please send an email to karen.vervisch@uzgent.be

ESCMID FUNDING

We also would like to emphasize that ESCMID is funding a selected number of registration fees. To apply for this funding, you can register for free via this link and send in your CV and motivation letter. If you experience problems, please contact William Caddy (william.caddy@escmid.org) or Karen Vervisch (Karen.vervisch@uzgent.be)